PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $10,894,000 | +26.0% | 181,055 | +17.2% | 1.39% | +19.1% |
Q3 2021 | $8,649,000 | -6.4% | 154,441 | +1.4% | 1.17% | -7.1% |
Q2 2021 | $9,244,000 | +39.4% | 152,332 | +61.0% | 1.26% | +34.4% |
Q1 2021 | $6,631,000 | -33.7% | 94,607 | -43.4% | 0.94% | -39.8% |
Q4 2020 | $10,006,000 | +19.4% | 167,217 | +20.0% | 1.56% | -2.0% |
Q3 2020 | $8,377,000 | +106.9% | 139,335 | +80.5% | 1.59% | +88.2% |
Q2 2020 | $4,049,000 | +6.4% | 77,175 | -12.8% | 0.84% | +5.9% |
Q4 2018 | $3,807,000 | -8.5% | 88,501 | -2.9% | 0.80% | +1.8% |
Q4 2017 | $4,161,000 | +48.6% | 91,161 | +55.3% | 0.78% | +23.3% |
Q2 2017 | $2,800,000 | -44.2% | 58,710 | -46.7% | 0.64% | -45.9% |
Q1 2017 | $5,021,000 | +189.1% | 110,120 | +235.8% | 1.17% | +132.0% |
Q1 2016 | $1,737,000 | -70.5% | 32,795 | -57.2% | 0.51% | -69.4% |
Q4 2015 | $5,885,000 | +125.0% | 76,639 | +107.2% | 1.65% | +253.0% |
Q2 2015 | $2,616,000 | -58.4% | 36,987 | -47.8% | 0.47% | -59.6% |
Q1 2015 | $6,291,000 | +23.6% | 70,808 | +23.3% | 1.16% | +17.7% |
Q4 2014 | $5,091,000 | +301.8% | 57,427 | +339.3% | 0.98% | +255.6% |
Q3 2014 | $1,267,000 | -78.9% | 13,071 | -89.6% | 0.28% | -79.4% |
Q3 2013 | $6,015,000 | -20.3% | 125,118 | -51.9% | 1.35% | -19.5% |
Q2 2013 | $7,543,000 | – | 260,112 | – | 1.67% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |